Cosmo and Hyundai Pharm Announce Signing of License Agreement for Winlevi® in Korea
Cosmo Pharmaceuticals N.V. (“Cosmo”) and Hyundai Pharmaceutical Co., Ltd. (“Hyundai Pharm”) today announced the signing of a License Agreement for Winlevi® (clascoterone) cream 1% in the Republic of Korea.